Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies. - Wikidata - wikimedia - TriplyDB

Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies.

Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies.

http://www.wikidata.org/entity/Q52561913

about

The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.Transcriptional regulation by targeted expression of architectural transcription factor high mobility group A2 in salivary glands of transgenic mice Let-7 microRNA and HMGA2 levels of expression are not inversely linked in adipocytic tumors: analysis of 56 lipomas and liposarcomas with molecular cytogenetic data.TLX1 and NOTCH coregulate transcription in T cell acute lymphoblastic leukemia cells.Refinement of 1p36 alterations not involving PRDM16 in myeloid and lymphoid malignancies Fine mapping of 14q24.1 breast cancer susceptibility locus Site-specific gene insertion mediated by a Cre-loxP-carrying lentiviral vector.Hmga2 is a direct target gene of RUNX1 and regulates expansion of myeloid progenitors in mice.Human HMGA2 protein overexpressed in mice induces precursor T-cell lymphoblastic leukemia 3'UTR-truncated Hmga2 cDNA causes MPN-like hematopoiesis by conferring a clonal growth advantage at the level of HSC in mice.The genetics of the myelodysplastic syndromes: classical cytogenetics and recent molecular insights.Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway Identification of microRNA-regulated pathways using an integration of microRNA-mRNA microarray and bioinformatics analysis in CD34+ cells of myelodysplastic syndromes.Translocations in epithelial cancers.Extramedullary hematopoiesis (EMH) in laboratory animals: offering an insight into stem cell research.Hmga2 promotes the development of myelofibrosis in Jak2V617F knockin mice by enhancing TGF-β1 and Cxcl12 pathways.Function of high-mobility group A proteins in the DNA damage signaling for the induction of apoptosis Transient JAK2 V617F mutation in an aplastic anaemia patient with a paroxysmal nocturnal haemoglobinuria clone.Identification of a novel fusion gene HMGA2-EGFR in glioblastoma.miR-9 is a tumor suppressor in pediatric AML with t(8;21).Silencing of HMGA2 reverses retardance of cell differentiation in human myeloid leukaemia.Quantitative expression analysis in peripheral blood of patients with chronic myeloid leukaemia: correlation between HMGA2 expression and white blood cell count.Dysregulation of the MIRLET7/HMGA2 axis with methylation of the CDKN2A promoter in myeloproliferative neoplasms.t(3;12)(q26;q14) in polycythemia vera is associated with upregulation of the HMGA2 gene

P2860

Q24681392-E3C46012-78F2-4602-B468-CA88823ABEE1 Q28586792-0DAFE055-E0A6-4836-9953-B0983E50894E Q33849130-C29CD490-32B6-46D7-B792-92B53047832F Q34036170-18682B7E-5146-456D-9E55-426745BEA2EE Q34062347-3E40DD0D-E317-467C-91BC-E85DBF7C1282 Q34158088-1ADF0AC9-3FBA-4575-AD5E-0F6C18C4FEAA Q34183407-38D868E5-EEBC-48D3-A8AF-D940D5FD40F2 Q34284318-B3A95B32-1E04-447C-BAC8-BD227024D83E Q34448869-8909C407-095A-4F1C-AE38-57A7B5A7C65E Q35037403-861684CA-D253-4173-9751-CAB34DD5FA46 Q36415991-004D90BE-EB28-4510-AA26-C429E33C5F3F Q36513525-A65675A5-0F33-4273-BEC0-4B4D0962C078 Q37215821-6B66DB1F-EA71-4E0F-8B70-16A4A89BAA16 Q37363960-929ED24A-989D-448C-A3F5-5B677655634C Q38342415-789072DC-836D-4E66-9603-350DC1318371 Q38715107-2CE16073-4E12-459C-B6AD-7C4FB1752397 Q41563900-34BC6B09-5C3B-48C3-9BFE-A4EE8683A4D9 Q43914228-0A85164C-5E1C-4204-9DC6-2AA54C42841D Q47343878-D3088750-0819-441F-A580-702C4BB5D2D7 Q48336259-04E1030F-C225-4D4D-9CD7-DB7C956EBC73 Q48518410-F608AA65-7816-484B-B516-4CAF1569CB23 Q53328370-EBAA77DB-04A4-46C4-BA75-712999BE8DDB Q55071119-7BD57D62-26E2-47BD-B48E-5DCC383AA7DF Q57690325-D67247C0-91F0-465E-B33A-258FD90B284D

P2860

Disruption and aberrant expression of HMGA2 as a consequence of diverse chromosomal translocations in myeloid malignancies.

http://www.wikidata.org/entity/Q52561913

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh

2005年學術文章

@zh-hant

name

Disruption and aberrant expres ...... tions in myeloid malignancies.

@en

Disruption and aberrant expres ...... tions in myeloid malignancies.

@nl

type

label

Disruption and aberrant expres ...... tions in myeloid malignancies.

@en

Disruption and aberrant expres ...... tions in myeloid malignancies.

@nl

prefLabel

Disruption and aberrant expres ...... tions in myeloid malignancies.

@en

Disruption and aberrant expres ...... tions in myeloid malignancies.

@nl

P1433

Q52561913-5FF25A3D-965B-4999-84F7-ABD34215DB44

P1476

Q52561913-74A2A45C-DBC8-41DF-829A-8AAC233BC465

P2093

Q52561913-1E65EB9E-4621-4AC0-BE5C-4711974B1D7A

Q52561913-29BB2D5C-BB63-4500-822E-43DEAAF528D6

Q52561913-2CF7BD54-F405-4091-BBDD-3EE79EAE1CC1

Q52561913-5D8F2B83-8289-43B9-B9DC-9D68B5325C90

Q52561913-8542366F-B074-43C5-A218-8FF191987A68

Q52561913-8566AE16-E02A-4B10-8653-9E1661EEBDB4

Q52561913-A6BBDB28-75F1-4A3F-B877-A75F8B08CD4C

Q52561913-AB1058FB-C8D6-4019-AB81-CAECE35F50CF

Q52561913-F8EE3AE5-D361-4B53-A24D-374402A354A7

P2860

Q52561913-00DF2693-B406-41AF-B7DA-5C3307100E02

Q52561913-06107909-ED8E-40C1-BF6C-429D44D6A91C

Q52561913-0890E918-86FC-46B8-A377-E32E0A9A91E6

Q52561913-0BCC6130-DD04-4E8F-AACC-1291072EFF00

Q52561913-19FAD285-58F1-49AD-A7C9-F6914A416E39

Q52561913-1F8C0415-9369-469F-9010-B64A6317A891

Q52561913-255459BB-7FC1-4070-8D9B-A32711C11E7C

Q52561913-27785D4A-E8C1-4DC2-BB65-84729069BB83

Q52561913-35565E0B-D512-475F-9150-F17424068A18

Q52561913-3BF93C8D-32D2-48A8-9C3C-B9D105238ABD

P2888

Q52561913-B9BC43D7-A7C5-4DDF-B6D6-22F6FE6A9CEB

P304

Q52561913-D5372121-41F0-40E5-A4E8-C4FCE89F43EB

P31

Q52561913-C1F64E9B-F834-4B95-BA8A-C85997FC96D6

P356

Q52561913-C6055366-8560-43FB-BC01-2026299851DC

P433

Q52561913-A7A247FD-41A6-4C11-8B4C-B1BCF39C2E67

P478

Q52561913-FE9D4D31-141A-4680-8839-95782E5DFC9A

P50

Q52561913-BE7C3E36-CEC8-4A73-AF7A-4442E49CEE00

P577

Q52561913-C45016EE-C66E-4DC1-BB1B-F87C5FEA91CE

P5875

Q52561913-B7F3498E-CE64-42C3-BDBA-49EE283AE85A

P6179

Q52561913-A20BD93E-13DC-4BEB-B77F-B29D0588E2A8

P698

Q52561913-736861C8-8AAA-4850-8787-3EFCA973E3E6

P356

P1433

P1476

Disruption and aberrant expres ...... tions in myeloid malignancies.

@en

P2093

Andrieux J

http://www.w3.org/2001/XMLSchema#string

Calasanz MJ

http://www.w3.org/2001/XMLSchema#string

Grand FH

http://www.w3.org/2001/XMLSchema#string

Iqbal S

http://www.w3.org/2001/XMLSchema#string

Laï JL

http://www.w3.org/2001/XMLSchema#string

Odero MD

http://www.w3.org/2001/XMLSchema#string

Roman JP

http://www.w3.org/2001/XMLSchema#string

Ross F

http://www.w3.org/2001/XMLSchema#string

Vizmanos JL

http://www.w3.org/2001/XMLSchema#string

P2860

LHFP, a novel translocation partner gene of HMGIC in a lipoma, is a member of a new family of LHFP-like genes

High mobility group A2 protein and its derivatives bind a specific region of the promoter of DNA repair gene ERCC1 and modulate its activity

Transcriptional activation of the cyclin A gene by the architectural transcription factor HMGA2

Disruption of the architectural factor HMGI-C: DNA-binding AT hook motifs fused in lipomas to distinct transcriptional regulatory domains

Functional interaction between the POU domain protein Tst-1/Oct-6 and the high-mobility-group protein HMG-I/Y

Regulation of cell-type-specific interleukin-2 receptor alpha-chain gene expression: potential role of physical interactions between Elf-1, HMG-I(Y), and NF-kappa B family proteins

hREC2, a RAD51-like gene, is disrupted by t(12;14) (q15;q24.1) in a uterine leiomyoma

Molecular dissection of the architectural transcription factor HMGA2

LPP, the preferred fusion partner gene of HMGIC in lipomas, is a novel member of the LIM protein gene family

Recurrent rearrangements in the high mobility group protein gene, HMGI-C, in benign mesenchymal tumours

P2888

P304

245-252

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.LEU.2403605

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

8111693

http://www.w3.org/2001/XMLSchema#string

P6179

1048232329

http://www.w3.org/2001/XMLSchema#string

P698

15618963

http://www.w3.org/2001/XMLSchema#string